DNA double-strand breaks (DSBs) can be accidentally introduced in cells by the action of ionizing radiation or certain reactive radicals. These agents have the ability to initiate a series of chemical reactions that ultimately sever the DNA backbone, resulting in chromosome breakage and fragmentation of genes (Hoeijmakers, 2001 ). Because such corruption of genetic material inevitably leads to problems with replication and cell division, it is of the utmost importance that cells have a mechanism to counteract DSBs. In addition, DSBs are generated in developing B and T cells during normal V(D)J recombination, implying that a working DSB repair system is not only necessary for an effective defense against DNA-modifying agents but also for a functional immune system in higher organisms (for review see Weterings and van Gent, 2004) . As a result, two highly effi cient DSB repair pathways have evolved in eukaryotic cells: homologous recombination (HR) and nonhomologous end joining (NHEJ).
The HR process mediates DSB repair by using a homologous DNA sequence as a template to guide proper restoration of the break. Because homologous templates are found on sister chromosomes, HR is thought to be active during the S and G2 cell cycle phases. Contrasting, NHEJ is characterized by its ability to directly ligate the two ends of the broken DNA molecule. This process does not have the need for a homologous template and is therefore theoretically not restricted to a certain phase of the cell cycle.
The general principle of NHEJ
The NHEJ pathway utilizes several enzymes that capture both DNA ends, bring them together in a synaptic complex, and facilitate direct ligation of the DNA break (Fig. 1) . The process is initiated by the association of DNA ends with the Ku 70/80 heterodimer, a protein with a ring-shaped structure that displays an extraordinary affi nity for open DNA ends (Walker et al., 2001 ). The DNA-Ku 70/80 complex then functions as a scaffold to assemble the other key NHEJ proteins at the DNA termini.
One of the fi rst enzymes to be attracted to the DNA-Ku 70/80 scaffold is a large, 460-kD serine/threonine kinase called DNA-dependent protein kinase catalytic subunit (DNA-PK CS ). The protein complex that is formed after the association of both Ku 70/80 and DNA-PK CS at the DNA ends is generally referred to as DNA-dependent protein kinase (DNA-PK). The large DNA-PK CS molecule forms a distinct structure at the DNA termini, which is likely to play an active role in the formation of a synaptic complex that holds the two ends of the broken DNA molecule together ( Fig. 1 ; for review see Weterings and van Gent, 2004) .
The positioning of the two DNA ends in a synaptic complex sets the stage for religation of the broken DNA molecule. Before this can take place effectively, it is necessary that noncomplementary ends are processed. In the case of single-stranded overhangs, DNA termini can be made ligatable by either fi lling of the missing nucleotides or by resection of the overhang. Polymerases μ and λ, terminal deoxynucleotidyltransferase, polynucleotide kinase, and several nucleases have been shown to play a role in this processing. The best-characterized processing nuclease is the endonuclease Artemis, whose activities include the removal of single-strand overhangs (Ma et al., 2002) . After correct processing, the two tethered DNA termini can fi nally be ligated. Ligation is mediated by the ligase IV-XRCC4 complex, possibly in conjunction with the recently discovered XLF (XRCC4-like factor)/Cernunnos protein (Ahnesorg et al., 2006) , although at this point, little is known about the mechanism by which XLF stimulates ligation. The DNA-dependent protein kinase (DNA-PK) is one of the central enzymes involved in DNA double-strand break (DSB) repair. It facilitates proper alignment of the two ends of the broken DNA molecule and coordinates access of other factors to the repair complex. We discuss the latest fi ndings on DNA-PK phosphorylation and offer a working model for the regulation of DNA-PK during DSB repair.
Correspondence to David J. Chen: david.chen@utsouthwestern.edu Abbreviations used in this paper: ATM, ataxia telangiectasia mutated; ATR, ataxia telangiectasia related protein; DSB, double-strand break; HR, homologous recombination; NHEJ, nonhomologous end joining. and a DNA terminus. This latter requirement makes the DNA-PK CS protein kinase truly DNA dependent. Many targets for the DNA-PK CS kinase have been identifi ed in vitro, including XRCC4, Ku 70/80, Artemis, p53, and even DNA-PK CS itself (autophosphorylation). This plethora of possible targets suggests that DNA-PK CS may be involved in several aspects of the NHEJ process, including activation of components of the synaptic complex and signal transduction to cell cycle regulators (Burma and Chen, 2004) . Surprisingly, however, little evidence has been found for the biological relevance of these activities. To the contrary, much more convincing data are available that argue for a regulatory role for DNA-PK CS at the synapsis of the two DNA ends during NHEJ.
Information on the shape and conformation of the DNAKu-DNA-PK CS complex is scarce and provides little detail as a result of technical diffi culties in the production of DNA-PK CS crystals for crystalographic structure studies. The best available information on the three-dimensional structure of the DNA-Ku-DNA-PK CS heterotrimer was obtained by singleparticle electron microscopy at a 25-Å resolution (Spagnolo et al., 2006) . These images clearly showed dimeric structures in which DNA ends were brought into close proximity by the formation of a synaptic complex that consisted of two DNA ends, two Ku 70/80 molecules, and two DNA-PK CS molecules (Fig. 1) . In addition, both atomic force microscopy studies and biochemical experiments have shown that DNA-PK CS not only assembles at DNA ends but also facilitates the tethering of multiple DNA ends (for review see Weterings and van Gent, 2004) . Collectively, these fi ndings suggest that DNA-PK CS is responsible for the formation of a synaptic bridge between the two termini of the broken DNA molecule.
It has been well established that the presence of the large DNA-PK CS molecule at DNA ends effectively blocks access of either processing nucleases or ligases (Weterings et al., 2003; Block et al., 2004) . Although this capping of DNA ends may have an important function in protection of the DNA termini against degradation or premature and incorrect ligation, it is clear that the DNA-PK CS cap has to be removed or altered before religation of the DNA ends and repair of the DSB can take place. Several authors have demonstrated that autophosphorylation of DNA-PK CS results in release of the cap and accessibility of the DNA termini for either processing enzymes or ligases (Ding et al., 2003; Weterings et al., 2003; Block et al., 2004) . Recent research has demonstrated that DNA-PK CS autophosphorylation can occur in trans during the synapsis of two DNA-bound DNA-PK CS molecules . These fi ndings clearly argue for a model in which DNA-PK CS protects the termini of a broken DNA molecule by capping it until the DNA ends fi nd each other and are properly aligned in a synaptic complex. DNA-PK CS trans-autophosphorylation then liberates the DNA ends for proper processing and ligation by other NHEJ factors like Artemis (Goodarzi et al., 2006) and ligase IV-XRCC4 (Block et al., 2004) . In this model, DNA-PK CS functions as a gatekeeper of the NHEJ process, regulating access to the DNA ends by autophosphorylation (Fig. 2) .
At present, it is not clear how we should envision the conformational changes in the DNA-DNA-PK CS complex that take place during autophosphorylation. It is also not unequivocally known which autophosphorylation sites need to be phosphorylated to facilitate the accessibility of DNA termini. Thus far, 16 amino acid residues that can be phosphorylated by the action of the DNA-PK CS kinase have been identifi ed within the DNA-PK CS molecule (Fig. 3) . The importance of DNA-PK CS autophosphorylation during NHEJ is demonstrated by numerous observations, showing that mutation of phosphorylation sites causes increased radiosensitivity and less effi cient DSB repair (Chan et al., 2002; Ding et al., 2003; Chen et al., 2005; Douglas et al., 2007) and that an active DNA-PK CS kinase is required for NHEJ (Kurimasa et al., 1999) .
Inhibiting phosphorylation of the entire 2609 cluster (Fig. 3 ) leads to a severe increase in radiosensitivity and diminished processing of DNA ends, whereas mutation of single residues within this cluster has a less severe (but still present) effect on radiosensitivity (Chan et al., 2002; Ding et al., 2003) . In addition, we found that mutation of either the DNA-PK CS kinase domain or the 2609 cluster and the 2056 residue results in a rigid binding of DNA-PK CS to DNA ends in vivo, which most likely interferes with the NHEJ process .
Collectively, these results demonstrate that autophosphorylation of the 2609 cluster infl uences the DNA-DNA-PK CS interaction in a manner that facilitates end joining.
In contrast, the 2056 cluster (Fig. 3) has been reported to inhibit DNA end processing upon phosphorylation, suggesting that the 2609 and 2056 clusters work in an opposite direction (Cui et al., 2005) . The latter fi nding has at present not been confi rmed, and it is not entirely transparent how this double regulation mechanism cooperates during DSB repair.
Phosphorylation of the recently discovered 3950 residue, which is located in the C-terminal kinase domain, most likely plays a role in regulation of the DNA-PK CS kinase activity. Mutation of this site with phosphomimic aspartic acid results in defi cient V(D)J recombination and increased radiation sensitivity . This fi nding suggests that the 3950 residue may be involved in the regulation of DNA-PK CS autophosphorylation by mediating kinase activity. Three other autophosphorylation sites have been identifi ed in the C-terminal region of DNA-PK CS (3821, 4026, and 4102), although no in vivo functionality has been reported for these sites at present (Ma et al., 2005) .
Other factors involved in DNA-PK CS phosphorylation
Recent experiments have shown that in vivo phosphorylation of the DNA-PK CS 2609 and 2647 residues can still occur at DSB sites in the absence of DNA-PK CS kinase activity Uematsu et al., 2007) . Clearly, in these cases, the DNA-PK CS molecule is not responsible for the phosphorylation events, and another kinase (or kinases) must be involved. These studies raise doubts as to whether all phosphorylation sites within the DNA-PK CS molecule are genuine autophosphorylation sites or whether they can be targets for other kinases as well.
One study reports that phosphorylation of the 2609 and 2647 residues (but not the 2056 residue) of DNA-PK CS is dependent on the ataxia telangiectasia mutated (ATM) protein . ATM is a damage-responsive protein kinase and a member of the phosphatidylinositol 3-kinase-like kinase group (PIKK), to which DNA-PK CS also belongs. Another study fi nds no absolute requirement for the presence of ATM but does acknowledge that several DNA-PK CS residues can be phosphorylated in the absence of a functional DNA-PK CS kinase, leaving open the possibility that ATM contributes to the phosphorylation of DNA-PK CS residues in vivo .
A third study suggests that yet another member of the PIKK group, ataxia telangiectasia related protein (ATR), is involved in the regulation of DNA-PK CS phosphorylation at the 2609 and 2647 residues after the onset of UV damage (Yajima et al., 2006) . At present, it is not clear whether the ATR-mediated phosphorylation of DNA-PK CS is relevant for DSB repair via the NHEJ pathway.
At this point, it is not known whether ATM (or ATR)-mediated phosphorylation of the DNA-PK CS 2609 and 2647 residues is redundant with autophosphorylation, but it is tempting to speculate that both routes of DNA-PK CS phosphorylation have their own biological signifi cance. ATM is activated at an early stage after the introduction of a DSB, is present at DSB sites, and is involved in signal transduction and phosphorylation of a plethora of proteins that mediate cell cycle arrest during DSB repair (Lobrich and Jeggo, 2005) . It is not unlikely that the ATM kinase, with its central role in the regulation of DSB repair and its physical presence at DSB sites, would be involved in regulation of the DNA-PK CS phosphorylation status and, thus, in regulation of the accessibility of DNA ends during the repair process.
Conclusions and speculations
It is becoming increasingly clear that DNA-PK CS plays a central role during the NHEJ process. This enzyme not only captures and tethers the two ends of a broken DNA molecule but also regulates the access of modifying enzymes and ligases to the DNA termini. A body of evidence supports a model in which regulation of the accessibility of DNA ends is mediated by autophosphorylation of DNA-PK CS in trans over the synaptic cleft between the two tethered DNA molecules (Fig. 2) .
The latest fi ndings that suggest the involvement of ATM in the phosphorylation of at least two DNA-PK CS residues open a new perspective on the regulation of DNA-PK CS in the synaptic complex. The codependence of DNA-PK CS phosphorylation on ATM would ensure that at least two signals need to be present before DNA-PK CS alters its conformation at the DNA ends:
(1) phosphorylation of the ATM-responsive sites within the DNA-PK CS molecule and (2) autophosphorylation in trans over the synaptic cleft. Such a mechanism would tightly control DNA-PK CS activity, not allowing access to the DNA termini until two criteria have been met: a defi ned DNA damage response (as indicated by activation of the ATM kinase) and a proper (Chan et al., 2002; Douglas et al., 2002) , 2056 cluster (Chen et al., 2005; Cui et al., 2005) , 3205 residue (Douglas et al., 2002) , 3950 residue , and 3821, 4026, and 4102 residues (Ma et al., 2005) are included. S, serine; T, threonine.
alignment of the two DNA ends. Until these criteria are met, the DNA termini will be protected by the DNA-PK CS molecule: a lock with multiple keys.
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